The total return over the past 12 months is -61.15% vs. +16.94% for the S&P 500. So far it's up -56.32% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (61.15%) | (46.54%) | (46.35%) | (39.10%) | N/A | N/A |
| Total Return CAGR | (61.15%) | (46.54%) | (46.35%) | (39.10%) | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Dare Bioscience, Inc. (DARE)
| Year | Start price | End price | DARE Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $1.93 | $0.84 | (56.32%) | +14.51% | (70.83%) |
| 2025 | $3.12 | $1.93 | (38.14%) | +17.72% | (55.86%) |
| 2024 | $3.71 | $3.12 | (15.90%) | +24.89% | (40.79%) |
| 2023 | $9.96 | $3.71 | (62.75%) | +26.19% | (88.94%) |
| 2022 | $24.00 | $9.96 | (58.50%) | (18.17%) | (40.33%) |
| 2021 | $16.08 | $24.00 | +49.25% | +28.74% | +20.51% |
| 2020 | $9.84 | $16.08 | +63.41% | +18.37% | +45.04% |
| 2019 | $8.53 | $9.84 | +15.36% | +31.22% | (15.86%) |
| 2018 | $25.97 | $8.53 | (67.15%) | (4.56%) | (62.59%) |
| 2017 | $84.98 | $25.97 | (69.44%) | +21.70% | (91.14%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
